Overview

A Study Of A New Medicine (GW597599B) For The Treatment Of Major Depressive Disorder

Status:
Completed
Trial end date:
2003-09-30
Target enrollment:
Participant gender:
Summary
A Placebo Controlled Study Evaluating Efficacy And Safety of Medication In Patients With Major Depressive Disorder (MDD)
Phase:
Phase 2
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Paroxetine
Vestipitant